The Teva Pharmaceutical Industries Ltd (TEVA) Lowered to Buy at Vetr Inc


Jefferies Group LLC cut shares of Teva Pharmaceutical Industries from a "buy" rating to a "hold" rating and cut their target price for the company from $69.00 to $40.00 in a research note on Sunday, December 4th. BTIG Research downgraded shares of Teva Pharmaceutical Industries from a "buy" rating to a "neutral" rating in a report on Sunday, December 4th.



from Biotech News